Details for New Drug Application (NDA): 021478
✉ Email this page to a colleague
The generic ingredient in ZOVIRAX is acyclovir sodium. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Pharmacology for NDA: 021478
| Mechanism of Action | DNA Polymerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 021478
Suppliers and Packaging for NDA: 021478
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ZOVIRAX | acyclovir | CREAM;TOPICAL | 021478 | NDA AUTHORIZED GENERIC | Teva Pharmaceuticals USA, Inc. | 0093-3630 | 0093-3630-20 | 1 TUBE in 1 CARTON (0093-3630-20) / 5 g in 1 TUBE |
| ZOVIRAX | acyclovir | CREAM;TOPICAL | 021478 | NDA | Bausch Health US, LLC | 0187-0994 | 0187-0994-45 | 1 TUBE in 1 CARTON (0187-0994-45) / 5 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 5% | ||||
| Approval Date: | Dec 30, 2002 | TE: | AB | RLD: | Yes | ||||
Expired US Patents for NDA 021478
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch | ZOVIRAX | acyclovir | CREAM;TOPICAL | 021478-001 | Dec 30, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
